Notably, dietary intervention with AGBR reduced TG, TC, LDL-c, and apolipoprotein-B levels and elevated HDL-c and apolipoprotein-A1 levels in patients with hyperlipidemia. This evidence concerns the gene APOA1 and hyperlipidemia.